Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography

Table 4 Correlations between optical coherence tomography measurements and various metabolic markers

Variables	Coefficients	SE	t	p value
For variability of NIT
MAGE	0.267	0.072	3.668	0.0006
Age	−0.071	0.278	−0.258	0.80
HbA1c	0.867	4.257	0.203	0.83
1,5 AG	−0.403	0.382	−1.054	0.29
Mean BG	0.210	0.131	1.596	0.11
Time in hypoglycemia	1.979	0.894	2.214	0.03
DM duration	0.738	0.473	1.560	0.12
HOMA R	−2.247	1.183	−1.899	0.06
Male	−12.36	8.000	−1.545	0.12
LDL cholesterol	0.002	0.152	0.018	0.98
HDL cholesterol	0.243	0.251	0.967	0.33
TG	−0.047	0.052	−0.902	0.37
CRP	−8.176	13.66	−0.598	0.55
For percentage of uncovered struts
MAGE	0.016	0.002	6.092	<0.0001
Age	0.020	0.011	1.740	0.11
HbA1c	0.183	0.180	1.016	0.31
1,5 AG	−0.028	0.016	−1.760	0.084
Mean BG	0.006	0.005	1.135	0.26
Time in hypoglycemia	0.072	0.039	1.835	0.072
DM duration	−0.018	0.020	−0.889	0.37
HOMA R	−0.067	0.051	−1.306	0.19
Male	0.710	0.334	2.122	0.039
LDL cholesterol	0.002	0.006	0.376	0.70
HDL cholesterol	0.009	0.010	0.850	0.39
TG	−0.001	0.002	−0.810	0.42
CRP	0.794	0.576	1.379	0.17

BG blood glucose, CRP C-reactive protein, DM diabetes mellitus, HbA1c glycated hemoglobin, HDL cholesterol: high-density lipoprotein cholesterol, HOMA R homeostasis model assessment ratio, LDL cholesterol low-density lipoprotein cholesterol, MAGE mean amplitude of glycemic excursion, TG triglycerides

ISSN: 1475-2840